Foreign Pharmacy Graduate Equivalency Examination FPGEE training questions are available, which are the best preparation material for you to study the test. The FPGEE is a comprehensive pharmacy exam, which focuses on knowledge from biomedical, pharmaceutical, behavioral, and clinical sciences. With studying FPGEE exam training questions, you can pass the test in a short time.
FPGEC FPGEE Exam
The FPGEE is a 5.5 hour exam comprised of 200 questions that are delivered in a computerized, fixed form. The scaled passing score is 75. To be eligible for the FPGEE, you must first apply for FPGEC Certification and complete the necessary steps. Applicants who become eligible during the FPGEC Certification process can take the FPGEE. When you become eligible, you receive a notification through your NABP e-Profile. The FPGEE is offered once per year at Pearson VUE test sites located throughout the continental United States.
FPGEE Exam Deadlines
Registration for the October 6, 2021 FPGEE opens on May 6, 2021.
The following are important dates for the October 6, 2021 FPGEE:
September 1 – Deadline for purchasing the FPGEE.
September 7 – Deadline to request a new FIC or submit a name change.
September 29 – Deadline for scheduling or cancelling an examination appointment at Pearson VUE.
Study NABP FPGEE Exam Training Questions
NABP certification FPGEE exam training questions can guarantee you success in the first attempt. Share some Foreign Pharmacy Graduate Equivalency Examination FPGEE exam training questions and answers below.
1.Both isoxazole and oxazole rings are found as substituents in some bacteriostatic sulfanilamides. They are present in these structures specifically because of their:
A. Sizes and shapes
B. Tautomeric activities
C. Enzymatic activities
D. Electron-donating effects
E. Electron-withdrawing effects
2.Uricosuric agents are used in gout treatment by inhibiting the uric acid re-absorption in the proximal tubules, the best example of a uricosuric agent is:
3.In an adequately powered, randomized controlled trial conducted over 3 years, a specific serious side effect (i.e. reduction in leukocytes) with conventional therapy is seen in 0.5% of the study sample. In patients who receive a newly discovered drug, only 0.45% experience the same side effect. Based on these results, the minimum number of patients that would have to receive the new drug for 3 years to statistically demonstrate the prevention of one episode of this side effect in at least one patient is:
4.Antimalarial drug used in the treatment of rheumatoid arthritis as DMRA-Disease-Modifying Antirheumatic Drug.
5.Which of the following are similarities between Cytochrome P450 and MAO?
A. Both add oxygen from O2 to substrates and also form water
B. Both carry out direct heteroatom oxidations
C. Both carry out oxidative deaminations
D. Both carry out N-dealkylations
E. All of the above